NYSE:LCIN

Lannett (LCIN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.02
$0.03
52-Week Range
N/A
Volume
441,200 shs
Average Volume
475,780 shs
Market Capitalization
$160,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Lannett

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

LCIN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive LCIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/25/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-231,620,000.00
Pretax Margin
-62.67%

Debt

Sales & Book Value

Annual Sales
$340.58 million
Book Value
($23.34) per share

Miscellaneous

Free Float
9,354,000
Market Cap
$160,000.00
Optionable
Optionable
Beta
0.92
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Timothy C. Crew
    Chief Executive Officer & Director
  • John Kozlowski
    Chief Financial Officer & Vice President-Finance
  • Robert Ehlinger
    Chief Information Officer & Vice President
  • Maureen M. Cavanaugh
    Chief Commercial Operations Officer & Senior VP
  • John M. Abt
    Chief Quality Operations Officer & Vice President

This page (NYSE:LCIN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners